Chronos Wealth Management
LLY icon

Chronos Wealth Management’s Eli Lilly LLY Stock Holding History

Chronos Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.4M Sell
20,264
-322
-2% -$380K 10.44% 1
2026
Q2 		$24.7M Sell
20,586
-341
-2% -$348K 10.96% 1
2026
Q1 		$19.2M Sell
20,927
-557
-3% -$565K 9.31% 1
2025
Q4 		$23.1M Sell
21,484
-475
-2% -$454K 10.69% 1
2025
Q3 		$16.8M Sell
21,959
-376
-2% -$280K 8.21% 1
2025
Q2 		$17.4M Buy
22,335
+550
+3% +$427K 9.02% 1
2025
Q1 		$18M Sell
21,785
-1,277
-6% -$1.06M 9.65% 1
2024
Q4 		$17.8M Sell
23,062
-158
-0.7% -$131K 9.09% 1
2024
Q3 		$20.6M Sell
23,220
-352
-1% -$316K 10.73% 1
2024
Q2 		$21.3M Sell
23,572
-626
-3% -$501K 11.86% 1
2024
Q1 		$18.8M Sell
24,198
-803
-3% -$571K 11.01% 1
2023
Q4 		$14.6M Sell
25,001
-1,918
-7% -$1.12M 9.27% 1
2023
Q3 		$14.5M Sell
26,919
-394
-1% -$203K 10.12% 1
2023
Q2 		$12.8M Sell
27,313
-927
-3% -$389K 8.86% 1
2023
Q1 		$9.7M Sell
28,240
-296
-1% -$100K 7.28% 3
2022
Q4 		$10.4M Sell
28,536
-1,183
-4% -$419K 8.24% 1
2022
Q3 		$9.6M Sell
29,719
-1,316
-4% -$417K 7.95% 1
2022
Q2 		$10.1M Sell
31,035
-5,636
-15% -$1.69M 7.54% 1
2022
Q1 		$10.5M Sell
36,671
-432
-1% -$111K 6.68% 3
2021
Q4 		$10.2M Sell
37,103
-225
-0.6% -$57K 6.21% 4
2021
Q3 		$8.62M Sell
37,328
-503
-1% -$124K 5.87% 5
2021
Q2 		$8.68M Buy
37,831
+390
+1% +$78.3K 5.96% 5
2021
Q1 		$7M Buy
37,441
+374
+1% +$73.2K 5.29% 6
2020
Q4 		$6.26M Buy
37,067
+376
+1% +$56.1K 5.13% 7
2020
Q3 		$5.43M Buy
36,691
+7,719
+27% +$1.19M 4.89% 7
2020
Q2 		$4.76M Buy
28,972
+4,588
+19% +$704K 4.6% 7
2020
Q1 		$3.38M Buy
24,384
+4,328
+22% +$595K 3.9% 12
2019
Q4 		$2.64M Buy
+20,056
New +$2.32M 2.59% 16

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Chronos Wealth Management's LLY Position: Q3 2026 in Review

Chronos Wealth Management reduced its Eli Lilly (LLY) stake by 1.6% in Q3 2026, selling an estimated $380K and leaving 20,264 shares worth $23.4M. The position accounts for 10.44% of the portfolio, ranked #1.

Chronos Wealth Management first reported a position in LLY in Q4 2019 and has held it in 28 quarters since. The position peaked at $24.7M in Q2 2026. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Chronos Wealth Management held 20,264 shares of Eli Lilly worth $23.4M as of Q3 2026.
  • Chronos Wealth Management sold 322 Eli Lilly shares in Q3 2026, an estimated $380K.
  • Eli Lilly made up 10.44% of Chronos Wealth Management's portfolio in Q3 2026, its #1 holding.
  • Chronos Wealth Management first reported a position in Eli Lilly in Q4 2019 and has held it in 28 quarters since.
  • Chronos Wealth Management's Eli Lilly position peaked at $24.7M in Q2 2026.
  • 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Chronos Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.